➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

Trifluridine - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for trifluridine and what is the scope of patent protection?

Trifluridine is the generic ingredient in two branded drugs marketed by Hi Tech, Sandoz Inc, and Monarch Pharms, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for trifluridine. Two suppliers are listed for this compound.

Drug Prices for trifluridine

See drug prices for trifluridine

Recent Clinical Trials for trifluridine

Identify potential brand extensions & 505(b)(2) entrants

Tom Baker Cancer CentrePhase 2
AHS Cancer Control AlbertaPhase 2

See all trifluridine clinical trials

Medical Subject Heading (MeSH) Categories for trifluridine

US Patents and Regulatory Information for trifluridine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc TRIFLURIDINE trifluridine SOLUTION/DROPS;OPHTHALMIC 074311-001 Oct 6, 1995 AT RX No No   Start Trial   Start Trial   Start Trial
Monarch Pharms VIROPTIC trifluridine SOLUTION/DROPS;OPHTHALMIC 018299-001 Approved Prior to Jan 1, 1982 AT RX Yes Yes   Start Trial   Start Trial   Start Trial
Hi Tech TRIFLURIDINE trifluridine SOLUTION/DROPS;OPHTHALMIC 205438-001 Jul 28, 2017 AT RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.